Musk’s Neuralink says it won FDA approval for human trials

AXIOS May 26, 2023
Adriel Bettelheim

Elon Musk’s Neuralink said it has been cleared by the Food and Drug Administration to begin human trials on its brain-implant technology.

Why it matters: The company hopes to someday treat neurological disorders with a chip but has drawn scrutiny over animal testing and issues involving the lithium battery of the device, per Reuters.

Driving the news: Neuralink on Thursday announced on Twitter that it received the go-ahead on human studies but didn’t elaborate on the trial’s objective.

• The approval marks “an important first step that will one day allow our technology to help many people,” the company said.
• An FDA spokesperson told Axios on Friday said the agency “acknowledges and understands” the company’s announcement, and that it may...

Today's Sponsors

Today's Sponsor